We aimed to describe the clinical presentation, treatment, outcome and report on factors
associated with mortality over a 90-day period in Clostridioides difficile infection (CDI) …

Objectives Clostridioides difficile infection (CDI) is a common healthcare-associated
infection and leading cause of gastroenteritis-related mortality worldwide. However, data on …

Structured summary Background Clostridioides difficile infection (CDI) increases the risk of
complications and mortality. We assessed the magnitude of these outcomes in a large …

Background Clostridium difficile infection (CDI) is a common cause of diarrhoea in
hospitalised patients. Around the world, the incidence and severity of CDI appears to be …

BACKGROUND: Clostridium difficile infection (CDI) is one of the most important healthcare-
associated infections, causing considerable mortality. Numerous severity scores have been …

Background: Limited and wide-ranging data are available on the recurrent Clostridioides
difficile infection (rCDI) incidence rate. Methods: We performed a cohort study with the aim to …

Background Current practice guidelines favour fidaxomicin over vancomycin and exclude
metronidazole from the recommended standard regimen for Clostridioides difficile infection …

Background Clostridioides difficile is a Gram-positive anaerobic bacterium, which causes
Clostridioides difficile infection (CDI). It has been recognised as a leading cause of …

Purpose Although an increase in burden of disease has frequently been reported for
Clostridium difficile infection (CDI), specific data on the effect of CDI on a patient's risk of …

Clostridioides difficile (C. difficile) is a Gram-positive, spore-forming, toxin-producing
anaerobic bacillus, which is one of the most common causes of health-care-associated …